• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ENDOTAK ENDURANCE RX; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ENDOTAK ENDURANCE RX; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT) Back to Search Results
Model Number 0144
Device Problems Over-Sensing (1438); Pacing Problem (1439); Pocket Stimulation (1463); Ambient Noise Problem (2877); Device Sensing Problem (2917)
Patient Problem Muscle Stimulation (1412)
Event Date 05/11/2016
Event Type  malfunction  
Manufacturer Narrative
This investigation will be updated should further information be provided.
 
Event Description
Boston scientific received information that this cardiac resynchronization therapy defibrillator (crt-d) and right ventricular (rv) lead had two stored episodes of noise with oversensing that led to pacing inhibition.The noise was unable to be reproduced with isometrics or pocket manipulation.Boston scientific technical services (ts) reviewed strips and noted the possibility that the patient was having diaphragmatic oversensing.Ts discussed additional testing.The system remains in service and the sensing was changed from nominal to 0.7 mv.No adverse patient effects were reported.
 
Manufacturer Narrative
Additional information was received that there was another episode of myopotential noise which was oversensed.The episode was three fast beats with a one second duration and then the patient's intrinsic beat came through.No further episodes have been reported.As no further information concerning this report is expected, our investigation is complete.This investigation will be updated should further information be provided.
 
Manufacturer Narrative
It was reported that this system has continued to exhibit noise, oversensing and pacing inhibition.There were no pacing pauses greater than two seconds and the patient was asymptomatic.The noise could be reproduced during isometrics.Due to the patient's age, the physician does not want to perform any invasive procedures.Therefore, some reprogramming was performed.A boston scientific technical services consultant reviewed the possible causes of the reported clinical observations.The patient will continue to be followed.No adverse patient effects were reported.
 
Event Description
This supplemental report is being filed due to the receipt of additional pertinent information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK ENDURANCE RX
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (NON-CRT)
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
GUIDANT PUERTO RICO, B.V.
no. 12, road 698
,
dorado PR 00646 3311
Manufacturer Contact
timothy degroot vasekar
4100 hamline avenue north
,
saint paul, MN 55112
6515826168
MDR Report Key5823848
MDR Text Key50515677
Report Number2124215-2016-09577
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date 08/06/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date03/26/2001
Device Model Number0144
Device Catalogue Number0144
Device Lot Number304097
Other Device ID NumberENDOTAK ENDURANCE RX
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 05/11/2016
Initial Date FDA Received07/26/2016
Supplement Dates Manufacturer Received08/28/2017
05/01/2019
Supplement Dates FDA Received11/07/2017
08/06/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age92 YR
-
-